India Glycols: NCLT Admits Second Motion Petition for Scheme of Arrangement
NCLT has admitted India Glycols Limited's Second Motion Petition for its Scheme of Arrangement. The order directs newspaper publications and notices to authorities, who have 30 days to respond. Further proceedings are scheduled for May 21, 2026. The scheme is subject to regulatory approvals.
The admission of the petition is a crucial step in the demerger process, which could significantly alter the company's structure and business operations. However, the scheme is still subject to further approvals and regulatory processes.
The NCLT's admission of the petition is a procedural step in the scheme of arrangement. While it moves the process forward, it does not guarantee the scheme's final approval, hence a neutral sentiment.
India Glycols Limited (IGL) has received a significant update regarding its Scheme of Arrangement. Following previous intimations, the National Company Law Tribunal (NCLT), Allahabad Bench, vide its order dated 9th April 2026 (made available online on 10th April 2026), has admitted the Second Motion Petition concerning the arrangement amongst India Glycols Limited (Demerged Company), Ennature Biopharma Limited (Resulting Company 1), and IGL Spirits Limited (Resulting Company 2).
The NCLT's order directs the company to undertake newspaper publications and issue notices to relevant authorities as specified under Section 230(5) of the Companies Act, 2013. These authorities have been given a 30-day period from the receipt of the notice to submit any representations.
The matter is scheduled for further proceedings on Thursday, 21st May 2026. The company has made the online copy of the NCLT's order available on its website, with a certified copy awaited. The Scheme of Arrangement remains subject to applicable regulatory and other approvals.
What to do with a filing like this
India Glycols Limited filed this with the NSE as a statutory disclosure, categorised under demerger. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.